ICR responds to NICE approval of new breakthrough drugs on the NHS for women with advanced breast cancer

The Institute of Cancer Research, London, welcomes the approval by NICE of a new type of treatment for women with previously untreated advanced breast cancer.
Institute of Cancer Research